COVID-19 Impact on Global Cryptococcosis Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: CF2CD6057E6CEN
QYResearch

Abstracts

This report focuses on the global Cryptococcosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cryptococcosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott
• Pfizer
• Bristol-Mayers Squibb
• Sigmapharm Laboratories
• Novartis
• Glenmark Pharmaceuticals

Market segment by Type, the product can be split into

• Amphotericin B
• Flucytosine
• Fluconazole
• Others

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacies
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cryptococcosis Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Cryptococcosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cryptococcosis Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cryptococcosis Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cryptococcosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Amphotericin B
  1.4.3 Flucytosine
  1.4.4 Fluconazole
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Cryptococcosis Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacies
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Cryptococcosis Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cryptococcosis Drugs Industry
    1.6.1.1 Cryptococcosis Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cryptococcosis Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cryptococcosis Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cryptococcosis Drugs Market Perspective (2015-2026)
2.2 Cryptococcosis Drugs Growth Trends by Regions
  2.2.1 Cryptococcosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cryptococcosis Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Cryptococcosis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cryptococcosis Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Cryptococcosis Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cryptococcosis Drugs Players by Market Size
  3.1.1 Global Top Cryptococcosis Drugs Players by Revenue (2015-2020)
  3.1.2 Global Cryptococcosis Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cryptococcosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cryptococcosis Drugs Market Concentration Ratio
  3.2.1 Global Cryptococcosis Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cryptococcosis Drugs Revenue in 2019
3.3 Cryptococcosis Drugs Key Players Head office and Area Served
3.4 Key Players Cryptococcosis Drugs Product Solution and Service
3.5 Date of Enter into Cryptococcosis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cryptococcosis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Cryptococcosis Drugs Forecasted Market Size by Type (2021-2026)

5 CRYPTOCOCCOSIS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cryptococcosis Drugs Market Size by Application (2015-2020)
5.2 Global Cryptococcosis Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cryptococcosis Drugs Market Size (2015-2020)
6.2 Cryptococcosis Drugs Key Players in North America (2019-2020)
6.3 North America Cryptococcosis Drugs Market Size by Type (2015-2020)
6.4 North America Cryptococcosis Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cryptococcosis Drugs Market Size (2015-2020)
7.2 Cryptococcosis Drugs Key Players in Europe (2019-2020)
7.3 Europe Cryptococcosis Drugs Market Size by Type (2015-2020)
7.4 Europe Cryptococcosis Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Cryptococcosis Drugs Market Size (2015-2020)
8.2 Cryptococcosis Drugs Key Players in China (2019-2020)
8.3 China Cryptococcosis Drugs Market Size by Type (2015-2020)
8.4 China Cryptococcosis Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cryptococcosis Drugs Market Size (2015-2020)
9.2 Cryptococcosis Drugs Key Players in Japan (2019-2020)
9.3 Japan Cryptococcosis Drugs Market Size by Type (2015-2020)
9.4 Japan Cryptococcosis Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cryptococcosis Drugs Market Size (2015-2020)
10.2 Cryptococcosis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cryptococcosis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Cryptococcosis Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Cryptococcosis Drugs Market Size (2015-2020)
11.2 Cryptococcosis Drugs Key Players in India (2019-2020)
11.3 India Cryptococcosis Drugs Market Size by Type (2015-2020)
11.4 India Cryptococcosis Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cryptococcosis Drugs Market Size (2015-2020)
12.2 Cryptococcosis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Cryptococcosis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Cryptococcosis Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Cryptococcosis Drugs Introduction
  13.1.4 Abbott Revenue in Cryptococcosis Drugs Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Cryptococcosis Drugs Introduction
  13.2.4 Pfizer Revenue in Cryptococcosis Drugs Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Bristol-Mayers Squibb
  13.3.1 Bristol-Mayers Squibb Company Details
  13.3.2 Bristol-Mayers Squibb Business Overview and Its Total Revenue
  13.3.3 Bristol-Mayers Squibb Cryptococcosis Drugs Introduction
  13.3.4 Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business (2015-2020)
  13.3.5 Bristol-Mayers Squibb Recent Development
13.4 Sigmapharm Laboratories
  13.4.1 Sigmapharm Laboratories Company Details
  13.4.2 Sigmapharm Laboratories Business Overview and Its Total Revenue
  13.4.3 Sigmapharm Laboratories Cryptococcosis Drugs Introduction
  13.4.4 Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business (2015-2020)
  13.4.5 Sigmapharm Laboratories Recent Development
13.5 Novartis
  13.5.1 Novartis Company Details
  13.5.2 Novartis Business Overview and Its Total Revenue
  13.5.3 Novartis Cryptococcosis Drugs Introduction
  13.5.4 Novartis Revenue in Cryptococcosis Drugs Business (2015-2020)
  13.5.5 Novartis Recent Development
13.6 Glenmark Pharmaceuticals
  13.6.1 Glenmark Pharmaceuticals Company Details
  13.6.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Glenmark Pharmaceuticals Cryptococcosis Drugs Introduction
  13.6.4 Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business (2015-2020)
  13.6.5 Glenmark Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cryptococcosis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Cryptococcosis Drugs Revenue
Table 3. Ranking of Global Top Cryptococcosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cryptococcosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Amphotericin B
Table 6. Key Players of Flucytosine
Table 7. Key Players of Fluconazole
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Cryptococcosis Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Cryptococcosis Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Cryptococcosis Drugs Players to Combat Covid-19 Impact
Table 14. Global Cryptococcosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Cryptococcosis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Cryptococcosis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Cryptococcosis Drugs Market Share by Regions (2015-2020)
Table 18. Global Cryptococcosis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Cryptococcosis Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Cryptococcosis Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Cryptococcosis Drugs Players
Table 25. Global Cryptococcosis Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Cryptococcosis Drugs Market Share by Players (2015-2020)
Table 27. Global Top Cryptococcosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cryptococcosis Drugs as of 2019)
Table 28. Global Cryptococcosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Cryptococcosis Drugs Product Solution and Service
Table 31. Date of Enter into Cryptococcosis Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Cryptococcosis Drugs Market Size Share by Type (2015-2020)
Table 35. Global Cryptococcosis Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Cryptococcosis Drugs Market Size Share by Application (2015-2020)
Table 37. Global Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Cryptococcosis Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 41. North America Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 43. North America Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 47. Europe Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 49. Europe Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 53. China Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 55. China Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 59. Japan Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 61. Japan Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 65. Southeast Asia Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 71. India Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 73. India Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Cryptococcosis Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Cryptococcosis Drugs Market Share (2019-2020)
Table 77. Central & South America Cryptococcosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Cryptococcosis Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Cryptococcosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Cryptococcosis Drugs Market Share by Application (2015-2020)
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Product
Table 84. Abbott Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 85. Abbott Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Bristol-Mayers Squibb Company Details
Table 92. Bristol-Mayers Squibb Business Overview
Table 93. Bristol-Mayers Squibb Product
Table 94. Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 95. Bristol-Mayers Squibb Recent Development
Table 96. Sigmapharm Laboratories Company Details
Table 97. Sigmapharm Laboratories Business Overview
Table 98. Sigmapharm Laboratories Product
Table 99. Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 100. Sigmapharm Laboratories Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Glenmark Pharmaceuticals Company Details
Table 107. Glenmark Pharmaceuticals Business Overview
Table 108. Glenmark Pharmaceuticals Product
Table 109. Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business (2015-2020) (Million US$)
Table 110. Glenmark Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cryptococcosis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Amphotericin B Features
Figure 3. Flucytosine Features
Figure 4. Fluconazole Features
Figure 5. Others Features
Figure 6. Global Cryptococcosis Drugs Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Other Case Studies
Figure 10. Cryptococcosis Drugs Report Years Considered
Figure 11. Global Cryptococcosis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cryptococcosis Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Cryptococcosis Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cryptococcosis Drugs Market Share by Players in 2019
Figure 16. Global Top Cryptococcosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cryptococcosis Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cryptococcosis Drugs Revenue in 2019
Figure 18. North America Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cryptococcosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 29. Bristol-Mayers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bristol-Mayers Squibb Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 31. Sigmapharm Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sigmapharm Laboratories Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 35. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Glenmark Pharmaceuticals Revenue Growth Rate in Cryptococcosis Drugs Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed